Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?

被引:11
|
作者
Melero Cortes, Lidia Maria [1 ]
Martinez Maestre, M. Angeles [1 ]
Vieites Perez-Quintela, M. Begona [2 ]
Gambadauro, Pietro [3 ,4 ]
机构
[1] Virgen del Rocio Univ Hosp, Gynecol Div, C Manuel Siurot S-N, Seville, Spain
[2] Virgen del Rocio Univ Hosp, Pathol Dept, Seville, Spain
[3] Uppsala Univ Hosp, Ctr Reprod, Uppsala, Sweden
[4] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden
关键词
Ovarian tumours; Sertoli-Leydig cell tumour; gynaecological endocrinology; hyperandrogenism; abnormal uterine bleeding; fertility preservation; OF-THE-LITERATURE; CLINICOPATHOLOGICAL ANALYSIS; MANAGEMENT;
D O I
10.1080/01443615.2017.1291590
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian Sertoli-Leydig cell tumours (OSLCT) are rare and typically present with androgenic manifestations in women of the 2nd-3rd decade. Out of 228 diagnoses of ovarian sex cord-stromal tumours recorded at an academic institution during a 14-year period, eight women were surgically treated for OSLCT. Patient mean age was 54.8years (range 19-81), five women being in the postmenopausal stage (62.5%). Only one woman presented with androgenic manifestations (12.5%), four with abnormal/postmenopausal uterine bleeding (50%), and three with abdominal pain (37.5%). Fertility sparing or radical surgery was performed depending on patient age and stage of disease. The only patient with an advanced disease (FIGO stage IV) was referred to palliative care postoperatively. The other seven were at FIGO stage I. Five of them were free from disease at a mean follow-up of 67months, while the remaining two were lost at follow-up. The youngest woman of the series, treated with fertility-preserving unilateral salpingo-oophorectomy at the age of 19, had two spontaneous pregnancies and deliveries of healthy babies during a 10-year follow-up period. In conclusion, our single institution 14-year experience demonstrates that the diagnosis of OSLCT is particularly challenging since many patients are older than expected and lack androgenic manifestations. Impact statement center dot What is already known on this subjectOvarian Sertoli-Leydig cell tumours (OSLCT) are rare and are thought to typically present with androgenic manifestations in women of the 2nd-3rd decade.center dot What the results of this study addOur single institution 14-year experience shows that a high proportion of women with ovarian Sertoli-Leydig cell tumours may not present with androgenic manifestations, and many of them also are in the postmenopausal stage. Most patients have a good prognosis and fertility-preserving surgery in younger women can lead to spontaneous pregnancies and deliveries of healthy children after treatment.center dot What are the implications of these findings for clinical practice and/or further researchThe diagnosis of OSLCT is particularly challenging and therefore not reached before surgery in most of the cases. However, while hysterectomy with bilateral salpingo-oophorectomy and surgical staging are recommended for women with higher stage or no fertility wish, fertility-sparing surgery should be considered in younger women with early disease. Therefore, further research should focus on non-invasive diagnosis possibly by means of laboratory or imaging techniques.
引用
收藏
页码:655 / 659
页数:5
相关论文
共 50 条
  • [31] The Oncogenic Roles of DICER1 RNase IIIb Domain Mutations in Ovarian Sertoli-Leydig Cell Tumors
    Wang, Yemin
    Chen, Jiamin
    Yang, Winnie
    Mo, Fan
    Senz, Janine
    Yap, Damian
    Anglesio, Michael S.
    Gilks, Blake
    Morin, Gregg B.
    Huntsman, David G.
    NEOPLASIA, 2015, 17 (08): : 650 - 660
  • [32] DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects
    Kato, Noriko
    Kusumi, Tomomi
    Kamataki, Akihisa
    Tsunoda, Rikiya
    Fukase, Masayuki
    Kurose, Akira
    HUMAN PATHOLOGY, 2017, 59 : 41 - 47
  • [33] Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors
    Gouy, Sebastien
    Arfi, Alexandra
    Maulard, Amandine
    Pautier, Patricia
    Bentivegna, Enrica
    Leary, Alexandra
    Chargari, Cyrus
    Genestie, Catherine
    Morice, Philippe
    ONCOLOGIST, 2019, 24 (05): : 702 - 709
  • [34] Postpartum Hemorrhage from Ruptured Sertoli-Leydig Cell Tumor A Case Report
    Riggs, John C.
    Zarghami, Faramarz
    Najid, Khadija
    Haber, Karina
    Schreffler, Susan M.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2010, 55 (9-10) : 433 - 436
  • [35] Sertoli-Leydig cell tumor with heterologous element: a case report and a review of the literature
    Chen, Longwen
    Tunnell, Cairo Dana
    De Petris, Giovanni
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (03): : 1176 - 1181
  • [36] Sertoli-Leydig cell tumors of the ovary: A Taiwanese Gynecologic Oncology Group study
    Weng, Chia-Sui
    Chen, Min-Yu
    Wang, Tao-Yeuan
    Tsai, Hsiao-Wen
    Hung, Yao-Ching
    Yu, Ken-Jen
    Chiang, Ying-Cheng
    Lin, Hao
    Lu, Chien-Hsing
    Chou, Hung-Hsueh
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2013, 52 (01): : 66 - 70
  • [37] Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature
    Durmus, Yasin
    Kilic, Cigdem
    Cakir, Caner
    Yuksel, Dilek
    Boran, Nurettin
    Karalok, Alper
    Boyraz, Gokhan
    Turan, Ahmet T.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 45 (07) : 1311 - 1318
  • [38] Ovarian Sertoli-Leydig Cell Tumor with Predominant Heterologous Mucinous Differentiation and Foci of Hepatocytic Differentiation: Case Report and Review of The Literature
    Liang, Li
    Menzin, Andrew
    Lovecchio, John Louis
    Navarro, Maria D.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2015, 45 (03): : 348 - 351
  • [39] Characteristics and prognostic implications of a cohort of 50 Sertoli-Leydig cell tumors at a single center
    Kang, Jia
    Mei, Dongyan
    Xing, Xiaoyan
    Cao, Yang
    Liang, Dandan
    Shi, Honghui
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 168 (02) : 613 - 619
  • [40] Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics
    Rabban, Joseph T.
    Karnezis, Anthony N.
    Devine, W. Patrick
    HISTOPATHOLOGY, 2020, 76 (01) : 11 - 24